Mats Jerkeman

1 – 10 of 197

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/960ac58f-efc9-4246-b2b3-22c9226a529e?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
19
20
next »

2025
Mark High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia : A community-based cohort study
Kebede, Habtamu Biazin ^LU ; Mekuria, Selamawit ^LU ; Asegid, Nahom ; Forslund, Ola ^LU ; Borgfeldt, Christer ^LU ; Jerkeman, Mats ^LU ; Mihret, Adane and Abebe, Tamrat (2025) In International Journal of Cancer 156(10). p.1995-2009
- Contribution to journal › Article
Mark Assessing the feasibility of HPV screening for cervical cancer in pregnant women in Ethiopia
Mekuria, Selamawit ^LU ; Assiged, Nahom ; Biazin, Habtamu ; Borgfeldt, Christer ^LU ; Abebe, Tamrat ; Mihret, Adane ; Forslund, Ola ^LU and Jerkeman, Mats ^LU (2025) In Scientific Reports 15(1).
- Contribution to journal › Article
Mark Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies
Harrysson, Sara ; Eloranta, Sandra ; Antonilli, Stefanie ; Runason Simonsen, Mikkel ; Sonnevi, Kristina ; Brown, Peter ; Wahlin, Bjorn E. ; Andersson, Per Ola ; Jørgensen, Judit M. and Jerkeman, Mats ^LU , et al. (2025) In British Journal of Haematology 206(6). p.1834-1839
- Contribution to journal › Letter
Mark Hypogammaglobulinemia at Diagnosis is Associated With Inferior Survival and Higher Risk of Infections in Diffuse Large B Cell Lymphoma
Lindberg, Åsa ^LU ; Johansson, Åsa ^LU ; Kahn, Fredrik ^LU ; Jönsson, Göran ^LU and Jerkeman, Mats ^LU (2025) In Hematological Oncology 43(1).
- Contribution to journal › Article
Mark Limited stage mantle cell lymphoma : A real-world study of primary treatment and prognosis in Sweden 2006–2018
Albertsson-Lindblad, Alexandra ^LU ; Ekberg, Sara ; Glimelius, Ingrid ; Ellin, Fredrik ^LU ; Sonnevi, Kristina ; Lewerin, Catharina ; Brandefors, Lena ; Smedby, Karin E. and Jerkeman, Mats ^LU (2025) In HemaSphere 9(1).
- Contribution to journal › Letter
Mark Peripheral T- and natural killer-cell lymphomas : ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ^☆
d'Amore, F. ; Federico, M. ; de Leval, L. ; Ellin, F. ^LU ; Hermine, O. ; Kim, W. S. ; Lemonnier, F. ; Vermaat, J. S.P. ; Wulf, G. and Buske, C. , et al. (2025) In Annals of Oncology 36(6). p.626-644
- Contribution to journal › Article
Mark Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
Jerkeman, Mats ^LU ; Mellgren, Karin ; Sonnevi, Kristina ; Lisak, Mikael ; Lagerlöf, Ingemar ; Kapas, Balazs ^LU ; Sjölund, Hanna ; Toporski, Jacek ; Hagberg, Hans and Mielke, Stephan , et al. (2025) In Leukemia 39(5). p.1256-1259
- Contribution to journal › Letter
Mark Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
Lewis, David J ; Jerkeman, Mats ^LU ; Sorrell, Lexy ; Wright, David ; Glimelius, Ingrid ; Poulsen, Christian B. ; Pasanen, Annika ; Rawstron, Andrew C. ; Wader, Karin Fahl and Morley, Nick , et al. (2025) In The Lancet
- Contribution to journal › Article
Mark Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
Sarkozy, Clémentine ; Chartier, Loïc ; Ribrag, Vincent ; Gressin, Remy ; Geisler, Christian H. ; Kluin-Nelemans, Hanneke C. ; Thieblemont, Catherine ; Morschhauser, Franck ; Lemonnier, François and Safar, Violaine , et al. (2025) In Blood Cancer Journal 15(1).
- Contribution to journal › Article
2024
Mark Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma
Hess, Georg ; Dreyling, Martin ; Oberic, Lucie ; Gine, Eva ; Zinzani, Pier Luigi ; Linton, Kim ; Vilmar, Adam ; Jerkeman, Mats ^LU ; Chen, Jenny M.H. and Ohler, Anke , et al. (2024) In Leukemia and Lymphoma 65(1). p.14-25
- Contribution to journal › Article

« previous
1
2
3
4
…
19
20
next »